학술논문

Identification of Pentosidine as a Native Structure for Advanced Glycation End Products in β 2-Microglobulin-Containing Amyloid Fibrils in Patients with Dialysis-Related Amyloidosis
Document Type
research-article
Source
Proceedings of the National Academy of Sciences of the United States of America, 1996 Mar . 93(6), 2353-2358.
Subject
Medical Sciences
Amyloids
Antibodies
Dialysis
Amyloid plaque
Urine
Diabetes complications
Macrophages
Diabetes
Rabbits
Bones
Language
English
ISSN
00278424
Abstract
β 2-Microglobulin (β 2m) is a major constituent of amyloid fibrils in patients with dialysis-related amyloidosis (DRA). Recently, we found that the pigmented and fluorescent adducts formed nonenzymatically between sugar and protein, known as advanced glycation end products (AGEs), were present in β 2m-containing amyloid fibrils, suggesting the possible involvement of AGE-modified β 2m in bone and joint destruction in DRA. As an extension of our search for the native structure of AGEs in β 2m of patients with DRA, the present study focused on pentosidine, a fluorescent cross-linked glycoxidation product. Determination by both HPLC assay and competitive ELISA demonstrated a significant amount of pentosidine in amyloid-fibril β 2m from longterm hemodialysis patients with DRA, and the acidic isoform of β 2m in the serum and urine of hemodialysis patients. A further immunohistochemical study revealed the positive immunostaining for pentosidine and immunoreactive AGEs and β 2m in macrophage-infiltrated amyloid deposits of long-term hemodialysis patients with DRA. These findings implicate a potential link of glycoxidation products in long-lived β 2m-containing amyloid fibrils to the pathogenesis of DRA.